Qube Research & Technologies Ltd - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,412,020
+113.8%
40,254
+157.3%
0.01%
+50.0%
Q2 2023$1,127,932
+192.2%
15,644
+198.1%
0.00%
+100.0%
Q1 2023$386,043
+53.4%
5,248
+39.3%
0.00%
+100.0%
Q4 2022$251,636
-63.6%
3,767
-53.0%
0.00%
-75.0%
Q3 2022$691,000
-62.9%
8,022
-61.6%
0.00%
-71.4%
Q2 2022$1,862,000
+121.9%
20,871
+179.8%
0.01%
+100.0%
Q1 2022$839,000
-51.5%
7,459
-51.8%
0.01%
-72.0%
Q2 2020$1,730,00015,4680.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders